Tick-borne encephalitis

The Lancet

Volumn 371, Issue 9627, 2008, Pages 1861-1871

  Lindquist, Lars ^a   Vapalahti, Olli ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN M; PLASMID DNA; TICK BORNE ENCEPHALITIS VACCINE; VIRUS RNA;

ATAXIA; BIOLOGY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; COGNITIVE DEFECT; CONSCIOUSNESS DISORDER; COST EFFECTIVENESS ANALYSIS; CRANIAL NERVE PARALYSIS; DIAGNOSTIC PROCEDURE; DRUG FORMULATION; DYSPHASIA; ELECTROENCEPHALOGRAM; ENZYME LINKED IMMUNOSORBENT ASSAY; EUROPE; FLAVIVIRUS; HEADACHE; HEALTH ECONOMICS; HEMIPARESIS; HUMAN; IMMUNIZATION; IXODES; JAPAN; LIFE CYCLE; MENINGOENCEPHALITIS; MORBIDITY; MYELITIS; NERVE PARALYSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PLASMAPHERESIS; PRIORITY JOURNAL; QUALITY OF LIFE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SEIZURE; SENSORY DYSFUNCTION; SPINAL NERVE; TICK BORNE ENCEPHALITIS; TREMOR; VIROLOGY; VIRUS TRANSMISSION;

EID: 44449135501     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)60800-4     Document Type: Review

References (141)

1. Schneider H. Uber epidemische akute Meningitis serosa. Wien Klin Wochenschr 44 (1931) 350-352
2. Kunz C., and Heinz F. Tick-borne encephalitis. Vaccine 21 (2003) S1-S2
3. WHO Regional Office for Europe (WHO/EURO). The vector-borne human infections of Europe: Their distribution and burden on public health (2004), WHO Regional Office for Europe (WHO/EURO), Copenhagen, Denmark 37-53. http://www.euro.who.int/document/e82481.pdf (accessed Dec 8, 2007).
4. Monath T., and Heinz F. Flaviviruses. In: Fields B., Knipe D., Howley P., et al. (Eds). Fields'virology. 3rd edn. Vol 1 (1996), Lippincott-Raven, Philadelphia 961-1034
5. Dumpis U., Crook D., and Oksi J. Tick-borne encephalitis. Clin Infect Dis 28 (1999) 882-890
6. Süss J. Epidemiology and ecology of TBE relevant to the production of effective vaccines. Vaccine 21 (2003) S19-S35
7. Gritsun T., Nuttall P., and Gould E. Tick-borne flaviviruses. Adv Virus Res 61 (2003) 317-371
8. Heinz F., and Allison S. Flavivirus structure and membrane fusion. Adv Virus Res 59 (2003) 63-97
9. Rey F., Heinz F., Mandl C., Kunz C., and Harrison S. The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution. Nature 375 (1995) 291-298
10. Lindenbach B., and Rice C. Molecular biology of flaviviruses. Adv Virus Res 59 (2003) 23-61
11. Best S., Morris K., Shannon J., et al. Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist. J Virol 79 (2005) 12828-12839
12. Heinz F., Allison S., Stiasny K., et al. Recombinant and virion-derived soluble and particulate immunogens for vaccination against tick-borne encephalitis. Vaccine 13 (1995) 1636-1642
13. Jääskeläinen A., Han X., Niedrig M., Vaheri A., and Vapalahti O. Diagnosis of tick-borne encephalitis with μ-capture IgM-EIA based on secreted recombinant antigen produced in insect cells. J Clin Microbiol 41 (2003) 4336-4342
14. Jacobs S., Stephenson J., and Wilkinson G. High-level expression of the tick-borne encephalitis virus NS1 protein by using an adenovirus-based vector: protection elicited in a murine model. J Virol 66 (1992) 2086-2095
15. Kofler R., Aberle J., Aberle S., Allison S., Heinz F., and Mandl C. Mimicking live flavivirus immunization with a noninfectious RNA vaccine. Proc Natl Acad Sci USA 101 (2004) 1951-1956
16. Kuno G., Chang G., Tsuchiya K., Karabatsos N., and Cropp C. Phylogeny of the genus Flavivirus. J Virol 72 (1998) 73-83
17. Grard G., Moureau G., Charrel R., et al. Genetic characterization of tick-borne flaviviruses: new insights into evolution, pathogenetic determinants and taxonomy. Virology 36 (2007) 80-92
18. Gaunt M., Sall A., de Lamballerie X., Falconar A., Dzhivanian T., and Gould E. Phylogenetic relationships of flaviviruses correlate with their epidemiology, disease association and biogeography. J Gen Virol 82 (2001) 1867-1876
19. Ecker M., Allison S., Meixner T., and Heinz F. Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia. J Gen Virol 80 (1999) 179-185
20. Lundkvist K., Vene S., Golovljova I., et al. Characterization of tick-borne encephalitis virus from Latvia: evidence for co-circulation of three distinct subtypes. J Med Virol 65 (2001) 730-735
21. Hayasaka D., Ivanov L., Leonova G., et al. Distribution and characterization of tick-borne encephalitis viruses from Siberia and far-eastern Asia. J Gen Virol 82 (2001) 1319-1328
22. Golovljova I., Vene S., Sjolander K., Vasilenko V., Plyusnin A., and Lundkvist A. Characterization of tick-borne encephalitis virus from Estonia. J Med Virol 74 (2004) 580-588
23. Jaenson T., Talleklint L., Lundqvist L., Olsen B., Chirico J., and Mejlon H. Geographical distribution, host associations, and vector roles of ticks (Acari: Ixodidae, Argasidae) in Sweden. J Med Entomol 31 (1994) 240-256
24. Haglund M., Vene S., Forsgren M., et al. Characterisation of human tick-borne encephalitis virus from Sweden. J Med Virol 71 (2003) 610-621
25. Jääskeläinen A., Tikkakoski T., Uzcategui N., Alekseev A., Vaheri A., and Vapalahti O. Siberian subtype tickborne encephalitis virus, Finland. Emerg Infect Dis 12 (2006) 1568-1571
26. Han X., Juceviciene A., Uzcategui N., et al. Molecular epidemiology of tick-borne encephalitis virus in Ixodes ricinus ticks in Lithuania. J Med Virol 77 (2005) 249-256
27. Waldenstrom J., Lundkvist A., Falk K., et al. Migrating birds and tickborne encephalitis virus. Emerg Infect Dis 13 (2007) 1215-1218
28. Alekseev A., and Chunikhin S. Transmission of the tick-borne encephalitis virus by ixodid ticks in the experiment (mechanisms, terms, species and sexual distinctions). Parazitologiia 24 (1990) 177-185
29. Kohl I., Kozuch O., Elecková E., Labuda M., and Zaludko J. Family outbreak of alimentary tick-borne encephalitis in Slovakia associated with a natural focus of infection. Eur J Epidemiol 12 (1996) 373-375
30. Kräusler J. 23 years of TBE in the district of Neunkirchen (Austria). In: Kunz C. (Ed). Tick-borne encephalitis (1981), Facultas, Vienna, Austria 6-12
31. Wahlberg P., Saikku P., and Brummer-Korvenkontio M. Tick-borne viral encephalitis in Finland: the clinical features of Kumlinge disease during 1959-1987. J Intern Med 225 (1989) 173-177
32. Vaisviliene D. TBE in Lithuania. In: Süss J., and Kahl O. (Eds). Proceedings of the Fourth International Potsdam Symposium on Tick-Borne Diseases (1997), Pabst Science Publishers, Lengerich 100-113
33. Avsic-Zupanc T., Poljak M., Maticic M., et al. Laboratory acquired tick-borne meningoencephalitis: characterisation of virus strains. Clin Diagn Virol 4 (1995) 51-59
34. Parola P., and Raoult D. Ticks and tickborne bacterial diseases in humans: an emerging infectious threat. Clin Infect Dis 32 (2001) 897-928
35. Krausler J. 23 years of TBE in the district of Neunkirchen (Austria). In: Kunz C. (Ed). Tick-borne encephalitis (1981), Facultas, Wien 6-12
36. Kaiser R. The clinical and epidemiological profile of tick-borne encephalitis in southern Germany 1994-98: a prospective study of 656 patients. Brain 122 (1999) 2067-2078
37. Lesnicar G., Poljak M., Seme K., and Lesnicar J. Pediatric tick-borne encephalitis in 371 cases from an endemic region in Slovenia, 1959 to 2000. Pediatr Infect Dis J 22 (2003) 612-617
38. Mickiene A., Laiskonis A., Günther G., Vene S., Lundkvist A., and Lindquist L. Tick-borne encephalitis in an area of high endemicity in Lithuania: disease severity and long-term prognosis. Clin Infect Dis 35 (2002) 650-658
39. Randolph S. The shifting landscape of tick-borne zoonoses: tick-borne encephalitis and Lyme borreliosis in Europe. Philos Trans R Soc Lond B Biol Sci 356 (2001) 1045-1056
40. Süss J., Schrader C., Falk U., and Wohanka N. Tick-borne encephalitis (TBE) in Germany: epidemiological data, development of risk areas and virus prevalence in field-collected ticks and in ticks removed from humans. Int J Med Microbiol 293 (2004) S69-S79
41. Haglund M., Forsgren M., Lindh G., and Lindquist L. A 10-year follow-up study of tick-borne encephalitis in the Stockholm area and a review of the literature: need for a vaccination strategy. Scand J Infect Dis 28 (1996) 217-224
42. Tomazic J., Pikelj F., Schwartz B., et al. The clinical features of tick-borne encephalitis in Slovenia. A study of 492 cases in 1994. Antibiotika Monitor 12 (1996) 115-120
43. Kunz C. TBE vaccination and the Austrian experience. Vaccine 21 (2003) S50-S55
44. Walder G., Lkhamsuren E., Shagdar A., et al. Serological evidence for tick-borne encephalitis, borreliosis, and human granulocytic anaplasmosis in Mongolia. Int J Med Microbiol 296 (2006) S69-S75
45. Randolph S., and Rogers D. Fragile transmission cycles of tick-borne encephalitis virus may be disrupted by predicted climate change. Proc R Soc Lond B Biol Sci 267 (2000) 1741-1744
46. Zeman P. Objective assessment of risk maps of tick-borne encephalitis and Lyme borreliosis based on spatial patterns of located cases. Int J Epidemiol 26 (1997) 1121-1129
47. Kozuch O., Labuda M., Lysy J., Weismann P., and Krippel E. Longitudinal study of natural foci of central European encephalitis virus in west Slovakia. Acta Virol 34 (1990) 537-544
48. Labuda M., Nuttall P., Kozuch O., et al. Non-viraemic transmission of tick-borne encephalitis virus: a mechanism for arbovirus survival in nature. Experientia 49 (1993) 802-805
49. Labuda M., Kozuch O., Zuffova E., Eleckova E., Hails R., and Nuttall P. Tick-borne encephalitis virus transmission between ticks cofeeding on specific immune natural rodent hosts. Virology 235 (1997) 138-143
50. Labuda M., Austyn J., Zuffova E., et al. Importance of localized skin infection in tick-borne encephalitis virus transmission. Virology 219 (1996) 357-366
51. Labuda M., Jones L., Williams T., and Nuttall P. Enhancement of tick-borne encephalitis virus transmission by tick salivary gland extracts. Med Vet Entomol 7 (1993) 193-196
52. Danielová V., and Holubová J. Transovarial transmission rates of tick-borne encephalitis virus in Ixodes ricinus ticks. In: Dusbabek F., and Bukva V. (Eds). Modern acarology Vol 2 (1991), SPB Academic Publishing, Prague, Czech Republic 7-10
53. Randolph S., Miklisova D., Lysy J., Rogers D., and Labuda M. Incidence from coincidence: patterns of tick infestation on rodents facilitate transmission of tick-borne encephalitis virus. Parasitology 118 (1999) 177-186
54. Randolph S., Green R., Peacey M., et al. Seasonal synchrony: the key to tick-borne encephalitis foci identified by satellite data. Parasitology 121 (2000) 15-23
55. Dobson A., Cattadori I., Holt R., et al. Sacred cows and sympathetic squirrels: the importance of biological diversity to human health. PLoS Med 3 (2006) e231
56. Daniel M., Danielova V., Kriz B., Jirsa A., and Nozicka J. Shift of the tick Ixodes ricinus and tick-borne encephalitis to higher altitudes in central Europe. Eur J Clin Microbiol Infect Dis 22 (2003) 327-328
57. Lindgren E., Talleklint L., and Polfeldt T. Impact of climatic change on the northern latitude limit and population density of the disease-transmitting European tick Ixodes ricinus. Environ Health Perspect 108 (2000) 119-123
58. Lindgren E., and Gustafson R. Tick-borne encephalitis in Sweden and climate change. Lancet 358 (2001) 16-18
59. WHO, WMO, UNEP. Climate change and human health: risk and responses. In: McMichael A. (Ed) (2003), WHO, Geneva
60. Sumilo D., Asokliene L., Bormane A., Vasilenko V., Golovljova I., and Randolph S. Climate change cannot explain the upsurge of tick-borne encephalitis in the Baltics. PLoS ONE 2 (2007) e500
61. Randolph S. Predicting the risk of tick-borne diseases. Int J Med Microbiol 291 suppl 33 (2002) 6-10
62. Sumilo D., Bormane A., Asokliene L., Lucenk I., Vasilenko V., and Randolph S. Tick-borne encephalitis in the Baltic States: identifying risk factors in space and time. Int J Med Microbiol 296 (2006) S76-S79
63. Randolph S. Ticks and tick-borne disease systems in space and from space. Adv Parasitol 47 (2000) 217-243
64. Günther G., Haglund M., Lindquist L., Forsgren M., and Sköldenberg B. Tick-bone encephalitis in Sweden in relation to aseptic meningoencephalitis of other etiology: a prospective study of clinical course and outcome. J Neurol 244 (1997) 230-238
65. Furlan S., and Strle F. Thrombocytopenia-a common finding in the initial phase of tick-borne encephalitis. Infection 23 (1995) 203-206
66. Gustafson R., Svenungsson B., Gardulf A., Stiernstedt G., and Forsgren M. Prevalence of tick-borne encephalitis and Lyme borreliosis in a defined Swedish population. Scand J Infect Dis 22 (1990) 297-306
67. Gustafson R., Svenungsson B., Forsgren M., Gardulf A., and Granstrom M. Two-year survey of the incidence of Lyme borreliosis and tick-borne encephalitis in a high-risk population in Sweden. Eur J Clin Microbiol Infect Dis 11 (1992) 894-900
68. Duniewicz M., Mertenova J., Moravcova E., et al. Central European tick-borne encephalitis from 1969 to 1972 in Central Bohemia. Infection 3 (1975) 223-228
69. Falisevac J., and Beus I. Clinical manifestations of tick-borne encephalitis in Croatia. In: Kunz C. (Ed). Tick-borne encephalitis (1981), Facultas, Vienna, Austria 13-19
70. Radsel-Medvescek A., Marolt-Gomiscek M., and Gajsek-Zima M. Clinical characteristics of patients with TBE treated at the University Medical Centre Hospital for Infectious Diseases in Lubljana during the years 1974 and 1977. In: Vesenjak-Hirjan J. (Ed). Arboviruses in the Mediterranean countries. Zbl Bakt Suppl 9 (1980), Gustav Fischer Verlag Stuttgart, New York 277-280
71. Krech T. Die Frühsommer-meningoenzephalitis (FSME) in der Schweiz. Thesis. Mediziniscnen fakultät (1980), Universität Bern, Bern
72. Jezyna C., Zajac W., and Pancewicz S. Epidemiologic and clinical studies of patients with tick-borne encephalitis from northeastern Poland. Zentralbl Bakteriol Mikrobiol Hyg 178 (1984) 510-521
73. Grygorczuk S., Mierzynska D., Zdrodowska A., et al. Tick-borne encephalitis in north-eastern Poland in 1997-2001: a retrospective study. Scand J Infect Dis 34 (2002) 904-909
74. Wahlberg P., Carlsson S., Granlund H., et al. TBE in Aland Islands 1959-2005: Kumlinge disease. Scand J Infect Dis 38 (2006) 1057-1062
75. Lorenzl S., Pfister H., Padovan C., and Yousry T. MRI abnormalities in tick-borne encephalitis. Lancet 347 (1996) 698-699
76. Marjelund S., Tikkakoski T., Tuieku S., et al. Magnetic resonance imaging findings and outcome in severe tick-borne encephalitis. Report of four cases and review of the literature. Acta Radiol 45 (2004) 88-94
77. Pikelj F., Tomazic M., Maticic M., Socan M., and Muzlovic I. Severe forms of tick-borne meningoencephalitis in Slovenia. J Infect 31 (1995) 83-85
78. Kaiser R. Tick-borne encephalitis in southwestern Germany. Infection 24 (1996) 398-399
79. Ackermann R., Kruger K., Roggendorf M., et al. Spread of early-summer meningoencephalitis in the Federal Republic of Germany. Dtsch Med Wochenschr 111 (1986) 927-933
80. Köck T., Stünzner D., Freidl W., and Pierer K. Clinical aspects of early summer meningoencephalitis in Styria. Nervenarzt 63 (1992) 205-208
81. Holmgren B., and Forsgren M. Epidemiology of tick-borne encephalitis in Sweden 1956-1989: a study of 1116 cases. Scand J Infect Dis 22 (1990) 287-295
82. Grubbauer H., Dornbusch H., Spork D., Zobel G., Trop M., and Zenz W. Tick-borne encephalitis in a 3-month-old child. Eur J Pediatr 151 (1992) 743-744
83. Iff T., Meier R., Olah E., et al. Tick-borne meningo-encephalitis in a 6-week-old infant. Eur J Pediatr 164 (2005) 787-788
84. Harasek G. Tick-borne encephalitis in children. Dtsch Med Wochenschr 99 (1974) 1965-1970
85. Falk W., and Lazarini W. TBE in childhood. In: Kunz C. (Ed). Tick-borne encephalitis (1981), Facultas, Vienna 20-24
86. Helwig H., Forster D., Neumann-Haefelin, and Staudt F. Die klinische bedeutung von FSME-virusinfektionen im kindesalter. Epidemiologie, verlauf, prognose und prophylaxe. Pädiat Praxis 28 (1983) 75-82
87. Messner H. Pediatric problems of TBE. In: Kunz C. (Ed). Tick-borne encephalitis (1981), Facultas, Vienna 25-27
88. Rakar R. Tick-borne meningoencephalitis. In: Lesnicar J. (Ed). Bedjanic symposion on tick-borne meningoencephalitis (1993), Infektoloska Sekcija SZD, Dobrna 37-41
89. Cizman M., Rakar R., Zakotnik B., Pokorn M., and Arnez M. Severe forms of tick-borne encephalitis in children. Wien Klin Wochenschr 111 (1999) 484-487
90. Fritsch P., Gruber-Sedlmayr U., Pansi H., et al. Tick-borne encephalitis in Styrian children from 1981 to 2005: a retrospective study and a review of the literature. Acta Paediatr 97 (2008) 535-538
91. Jones N., Sperl W., Koch J., Holzmann H., and Radauer W. Tick-borne encephalitis in a 17-day old newborn resulting in severe neurologic impairment. Pediatr Infect Dis J 26 (2007) 185-186
92. Kluger G., Schöttler A., Waldvogel K., et al. Tick-borne encephalitis despite specific immunoglobulin prophylaxis. Lancet 346 (1995) 1502
93. Waldvogel K., Bossart W., Huisman T., Boltshauser E., and Nadal D. Severe tick borne encephalitis following passive immunization. Eur J Pediatr 155 (1996) 775-779
94. Schmolck H., Maritz E., Kletzin I., and Korinthenberg R. Neurologic, neuropsychologic, and electroencephalographic findings after European tick-borne encephalitis in children. J Child Neurol 20 (2005) 500-508
95. Kaiser R., and Holzmann H. Laboratory findings in tick-borne encephalitis-correlation with clinical outcome. Infection 28 (2000) 78-84
96. Günther G., Haglund M., Lindquist L., Sköldenberg B., and Forsgren M. Intrathecal IgM, IgA and Igb antibody response in tick-borne encephalitis. Long-term follow-up related to clinical course and outcome. Clin Diagn Virol 8 (1997) 17-29
97. Heinz F. Molecular aspects of TBE virus research. Vaccine 21 (2003) 3-10
98. McMinn P. The molecular basis of virulence of the encephalitogenic flaviviruses. J Gen Virol 78 (1997) 2711-2722
99. Gelpi E., Preusser M., Garzuly F., Holzmann H., Heinz F., and Budka H. Visualization of Central European tick-borne encephalitis in fatal human cases. J Neuropathol Exp Neurol 64 (2005) 506-512
100. Günther G., Haglund M., Lindquist L., Sköldenberg B., and Forsgren M. Intrathecal production of neopterin and beta 2 microglobulin in tick-borne encephalitis (TBE) compared to meningoencephalitis of other etiology. Scand J Infect Dis 28 (1996) 131-138
101. Dekonenko E., and Umanskij K. Sequelae of different clinical forms of the acute stage of tick-borne encephalitis. Zh Nevropatol Psikhiatr Im S S Korsakova 84 (1985) 202-207
102. Bannova G., and Sarmanova E. Biological properties of tick-borne encephalitis strains isolated in different parts of its geographic range. Vopr Virusol 1 (1982) 41-45
103. Korenberg E., and Kovalevski Y. Main features of tick-borne encephalitis eco-epidemiology in Russia. Zent Bakteriol 289 (1999) 525-539
104. Gustafson R., Forsgren M., Gardulf A., Granström M., and Svenungsson B. Clinical manifestations and antibody prevalence of Lyme borreliosis and tick-borne encephalitis in Sweden: a study in five endemic areas close to Stockholm. Scand J Infect Dis 25 (1993) 595-603
105. Paponnikova T. Specific clinical and epidemiological features of tick-borne encephalitis in Western Siberia. Int J Med Microbiol 296 (2006) 59-62
106. Gritsun T., Frolova T., Zhankov A., et al. Characterization of a Siberian virus isolated from a patient with progressive chronic tick-borne encephalitis. J Virol 77 (2003) 25-36
107. Naslednikova I., Ryazantseva N., Novitskii V., et al. Chronic tick-borne encephalitis virus antigenemia: possible pathogenesis pathways. Bull Exp Biol Med 139 (2005) 451-454
108. Ternovoi V., Kurzhukov G., Sokolov Y., et al. Tick-borne Encephalitis with Hemorrhagic Syndrome, Novosibirsk Region, Russia, 1999 Emerg Infect Dis (serial online) (2003 June). http//www.cdc.gov/ncidod/EID/vol9no6/03-0007htm (accessed Sept 5, 2007).
109. Puchhammer-Stöckl E., Kunz C., Mandl C., and Heinz F. Identification of tick-borne encephalitis virus ribonucleic acid in tick suspensions and in clinical specimens by a reverse transcription-nested polymerase chain reaction assay. Clin Diagn Virol 4 (1995) 321-326
110. Holzmann H. Diagnosis of tick-borne encephalitis. Vaccine 21 (2003) S36-S40
111. Demicheli V., Graves P., Pratt M., and Jefferson T. Vaccines for preventing tick-borne encephalitis. Cochrane Database Syst Rev 2 (2000) CD000977.
112. Hayasaka D., Goto A., Yoshii K., Mizutani T., Kariwa H., and Takashima I. Evaluation of European tick-borne encephalitis virus vaccine against recent Siberian and far-eastern subtype strains. Vaccine 19 (2001) 4774-4779
113. Holzmann H., Vorobyova M., Ladyzhenskaya I., et al. Molecular epidemiology of tick-borne encephalitis virus: cross-protection between European and Far Eastern subtypes. Vaccine 10 (1992) 345-349
114. Kunz C., Heinz F., and Hofmann H. Immunogenicity and reactogenicity of a highly purified vaccine against tick-borne encephalitis. J Med Virol 6 (1980) 103-109
115. Kunz C., Hofmann H., and Dippe H. Early summer meningoencephalitis vaccination, a preventive medicine measure with high acceptance in Austria. Wien Med Wochenschr 141 (1991) 273-276
116. Craig S., Pittman P., Lewis T., et al. An accelerated schedule for tick-borne encephalitis vaccine: the American Military experience in Bosnia. Am J Trop Med Hyg 61 (1999) 874-878
117. Chiba N., Osada M., Komoro K., Mizutani T., Kariwa H., and Takashima I. Protection against tick-borne encephalitis virus isolated in Japan by active and passive immunization. Vaccine 17 (1999) 1532-1539
118. Loew-Baselli A., Konior R., Pavlova B., et al., for the FSME-IMMUN((R)) study group. Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN((R)): Results of two large phase 3 clinical studies. Vaccine 24 (2006) 5256-5263
119. Zent O., Jilg W., Plentz A., et al. Kinetics of the immune response after primary and booster immunization against tick-borne encephalitis (TBE) in adults using the rapid immunization schedule. Vaccine 21 (2003) 4655-4660
120. Zent O., Beran J., Jilg W., Mach T., and Banzhoff A. Clinical evaluation of a polygeline-free tick-borne encephalitis vaccine for adolescents and adults. Vaccine 21 (2003) 738-741
121. Beran J., Douda P., Gniel D., and Zent O. Long-term immunity after vaccination against tick-borne encephalitis with Encepur using the rapid vaccination schedule. Int J Med Microbiol 293 (2004) 130-133
122. Rendi-Wagner P., Kundi M., Zent O., et al. Immunogenicity and safety of a booster vaccination against tick-borne encephalitis more than 3 years following the last immunisation. Vaccine 23 (2004) 427-434
123. Bender A., Jager G., Scheuerer W., Feddersen B., Kaiser R., and Pfister H. Two severe cases of tick-borne encephalitis despite complete active vaccination: the significance of neutralizing antibodies. J Neurol 251 (2004) 353-354
124. Kunze U., Baumhackl U., Bretschneider R., et al. The golden agers and tick-borne encephalitis. Conference report and position paper of the International Scientific Working Group on Tick-borne Encephalitis. Wien Med Wochenschr 155 (2005) 289-294
125. Holzmann H., Kundi M., Stiasny K., et al. Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis. J Med Virol 48 (1996) 102-107
126. Guirakhoo F., Heinz F., Dippe H., and Kunz C. Antibody response to gp E of tick-borne encephalitis virus: comparison between natural infection and vaccination breakdown. Zentralbl Bakteriol 272 (1990) 477-484
127. Rendi-Wagner P., Kundi M., Zent O., et al. Immunogenicity and safety of a booster vaccination against tick-borne encephalitis more than 3 years following the last immunisation. Vaccine 23 (2004) 427-434
128. Girgsdies O., and Rosenkranz G. Tick-borne encephalitis: development of a paediatric vaccine. A controlled, randomized, double-blind and multicentre study. Vaccine 14 (1996) 1421-1428
129. Hainz U., Jenewein B., Asch E., Pfeiffer K., Berger P., and Grubeck-Loebenstein B. Insufficient protection for healthy elderly adults by tetanus and TBE vaccines. Vaccine 23 (2005) 3232-3235
130. Zent O., Plentz A., Schwarz T., et al. TBE booster immunization according to the rapid immunization schedule: are 3-year booster intervals really necessary?. Vaccine 23 (2004) 312-315
131. Kunz C., Hofmann H., and Dippe H. Early summer meningoencephalitis vaccination, a preventive medicine measure with high acceptance in Austria. Wien Med Wochenschr 141 (1991) 273-276
132. Rendi-Wagner P., Kundi M., Zent O., et al. Persistence of protective immunity following vaccination against tick-borne encephalitis: longer than expected?. Vaccine 22 (2004) 2743-2749
133. Loew-Baselli EM, Poellabauer, Fritschs, et al. FSME-IMMUN 05 ml using a rapid immunization schedule. Proceedings of the 8th International potsdam symposium on tick-borne diseases. Jena, Germany; March 10-12, 2005.
134. Beran J., Douda P., Gniel D., et al. Long-term immunity after vaccination against tick-borne encephalitis with Encepur using the rapid vaccination schedule. Int J Med Microbiol 293 (2004) S130-S133
135. Schöndorf I., Beran J., Cizkova D., Lesna V., Banzhoff A., and Zent O. Tick-borne encephalitis (TBE) vaccination: applying the most suitable vaccine schedule. Vaccine 25 (2007) 1470-1475
136. Schwarz B. Health economics of early summer meningoencephalitis in Austria. Effects of a vaccination campaign 1981 to 1990. Wien Med Wochenschr 143 (1993) 551-555
137. Scholz E., and Wietholter H. Postvaccinal neuritis following prophylactic vaccination against early-summer meningo-encephalitis. Dtsch Med Wochenschr 112 (1987) 544-546
138. Hofmann H. After vaccination for tick-borne encephalitis must onset of neurologic disorders be expected?. Wien Klin Wochenschr 107 (1995) 509-515
139. Ehrlich H., Pavlova B., Fritsch S., et al. Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity. Vaccine 22 (2003) 217-223
140. Zent O., Banzhoff A., Hilbert A., Meriste S., Sluzewski W., and Wittermann C. Safety, immunogenicity and tolerability of a new pediatric tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer. Vaccine 21 (2003) 3584-3592
141. Pavlova B., Loew-Baselli A., Fritsch S., et al. Tolerability of modified tick-borne encephalitis vaccine FSME-IMMUN "NEW" in children: results of post-marketing surveillance. Vaccine 21 (2003) 742-745